Hot Undervalued Stocks To Buy For 2019

Investment Thesis

I am optimistic about Kohl’s (KSS) because their stock price appears undervalued. They continue to beat their competitors in areas that are important such as revenue, ROIC, store productivity, and e-commerce.

Source: Time.com

Kohl’s reported a comparable sales increase of 6.3% and reported diluted earnings per share of $5.12 in their fourth-quarter press release. In the last year, Kohl’s stock price nearly doubled from $39.59 in May of 2017 to $66.91 today. Kohl’s is keeping up its momentum by opening up stores, while many of its competitors are closing stores.

Hot Undervalued Stocks To Buy For 2019: United Natural Foods, Inc.(UNFI)

Advisors’ Opinion:

  • [By Chris Lange]

    When United Natural Foods Inc. (NASDAQ: UNFI) reported its most recent quarterly results after the markets closed on Thursday, the company said that it had $0.76 in earnings per share (EPS) and $2.59 billion in revenue. Consensus estimates had called for $0.85 in EPS and revenue of $2.61 billion, and the fiscal fourth quarter of last year reportedly had EPS of $0.72 and $2.34 billion in revenue.

  • [By Max Byerly]

    Here are some of the headlines that may have effected Accern Sentiment’s rankings:

    Get United Natural Foods alerts:

    Can United Natural's Growth Strategies Wipe Off Cost Woes? (finance.yahoo.com) United Natural Foods Inc (UNFI) Given Average Recommendation of “Hold” by Brokerages (americanbankingnews.com) Free Post Earnings Research Report: United Natural Foods’ Sales Jumped 11.8%; Adjusted EPS Soared 35.1% (finance.yahoo.com) 4 Stocks That Will Benefit From the Weight Crisis (investorplace.com)

    A number of equities research analysts have issued reports on the company. Citigroup cut their price target on United Natural Foods from $53.00 to $49.00 and set a “buy” rating for the company in a research note on Thursday, June 21st. ValuEngine upgraded United Natural Foods from a “sell” rating to a “hold” rating in a research note on Monday, June 18th. Pivotal Research cut their price target on United Natural Foods from $34.00 to $33.00 and set a “sell” rating for the company in a research note on Wednesday, June 13th. Zacks Investment Research upgraded United Natural Foods from a “hold” rating to a “buy” rating and set a $52.00 price target for the company in a research note on Friday, June 8th. Finally, BMO Capital Markets cut their price target on United Natural Foods from $50.00 to $41.00 and set a “market perform” rating for the company in a research note on Friday, June 8th. Four research analysts have rated the stock with a sell rating, ten have assigned a hold rating and five have issued a buy rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus price target of $45.51.

  • [By Steve Symington]

    Shares of SUPERVALU Inc. (NYSE:SVU) soared 57.5% in the month of July, according to data from S&P Global Market Intelligence, after the supermarket chain agreed to be acquired by United Natural Foods (NASDAQ:UNFI).

Hot Undervalued Stocks To Buy For 2019: Rogers Corporation(ROG)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Rogers (NYSE: ROG) and Kraton (NYSE:KRA) are both computer and technology companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, profitability, dividends, institutional ownership, valuation, analyst recommendations and earnings.

  • [By Logan Wallace]

    Rogers (NYSE:ROG) was downgraded by investment analysts at ValuEngine from a “buy” rating to a “hold” rating in a note issued to investors on Monday.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Rogers (ROG)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Trinseo (NYSE: TSE) and Rogers (NYSE:ROG) are both mid-cap basic materials companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, risk, profitability, earnings, valuation and dividends.

  • [By Shane Hupp]

    Kepler Capital Markets set a CHF 249 target price on Roche Holding Ltd. Genussscheine (VTX:ROG) in a research note issued to investors on Wednesday morning. The brokerage currently has a neutral rating on the healthcare company’s stock.

  • [By Joseph Griffin]

    Kepler Capital Markets set a CHF 249 target price on Roche Holding Ltd. Genussscheine (VTX:ROG) in a research note issued to investors on Wednesday morning. The brokerage currently has a neutral rating on the healthcare company’s stock.

Hot Undervalued Stocks To Buy For 2019: Green Brick Partners, Inc.(GRBK)

Advisors’ Opinion:

  • [By Max Byerly]

    M/I Homes (NASDAQ: GRBK) and Green Brick Partners (NASDAQ:GRBK) are both small-cap construction companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, valuation, risk, institutional ownership, dividends, profitability and earnings.

  • [By Joseph Griffin]

    Green Brick Partners (NASDAQ:GRBK) was downgraded by BidaskClub from a “hold” rating to a “sell” rating in a research note issued to investors on Friday.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Green Brick Partners (GRBK)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Undervalued Stocks To Buy For 2019: Harsco Corporation(HSC)

Advisors’ Opinion:

  • [By Joseph Griffin]

    HashCoin (CURRENCY:HSC) traded 2.5% lower against the US dollar during the 1 day period ending at 20:00 PM ET on September 30th. HashCoin has a total market capitalization of $0.00 and $28,133.00 worth of HashCoin was traded on exchanges in the last day. One HashCoin token can currently be purchased for approximately $0.0004 or 0.00000005 BTC on exchanges including Gate.io and BCEX. Over the last week, HashCoin has traded down 5.5% against the US dollar.

  • [By Max Byerly]

    Principal Financial Group Inc. boosted its position in shares of Harsco Co. (NYSE:HSC) by 2.4% during the 1st quarter, HoldingsChannel reports. The fund owned 654,139 shares of the industrial products company’s stock after buying an additional 15,559 shares during the quarter. Principal Financial Group Inc.’s holdings in Harsco were worth $13,508,000 as of its most recent filing with the Securities and Exchange Commission.

  • [By Ethan Ryder]

    Harsco (NYSE:HSC) – Research analysts at KeyCorp lifted their Q2 2018 earnings estimates for Harsco in a report issued on Wednesday, May 2nd. KeyCorp analyst J. Hammond now expects that the industrial products company will post earnings per share of $0.35 for the quarter, up from their prior forecast of $0.31. KeyCorp has a “Overweight” rating and a $27.00 price objective on the stock. KeyCorp also issued estimates for Harsco’s Q3 2018 earnings at $0.36 EPS, Q4 2018 earnings at $0.27 EPS, FY2018 earnings at $1.20 EPS and FY2019 earnings at $1.35 EPS.

Hot Undervalued Stocks To Buy For 2019: LivaNova PLC(LIVN)

Advisors’ Opinion:

  • [By Shane Hupp]

    LivaNova (NASDAQ:LIVN) and Masimo (NASDAQ:MASI) are both mid-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, dividends, analyst recommendations, valuation, risk and profitability.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on LivaNova (LIVN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    LivaNova (NASDAQ: LIVN) and Aradigm (NASDAQ:ARDM) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, dividends, institutional ownership, analyst recommendations, risk and profitability.

  • [By Lisa Levin] Gainers
    Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares surged 144.96 percent to close at $265.61 on Thursday in reaction to an encouraging Phase 2 clinical trial update. The clinical-stage biopharmaceutical company said its liver-directed, thyroid hormone receptor called MGL-3196 showed a statistical significance in the primary endpoint of lowering liver fat at 12 weeks and also 36 weeks.
    Viking Therapeutics, Inc. (NASDAQ: VKTX) shares rose 101.01 percent to close at $9.99 on Thursday after falling 4.42 percent on Wednesday.
    Akers Biosciences, Inc. (NASDAQ: AKER) jumped 45.58 percent to close at $0.474. The developer of rapid health information technologies said Wednesday afternoon it was granted a 180-day extension from the Nasdaq Stock Market to meet the requirement of a minimum $1.00 per share closing bid price for 10 straight days.
    Kitov Pharma Ltd (NASDAQ: KTOV) gained 40.93 percent to close at $3.03 after the FDA approved Kitov's Consensi for the treatment of osteoarthritis pain and hypertension.
    China Customer Relations Centers, Inc. (NASDAQ: CCRC) rose 28.21 percent to close at $19.86.
    J.Jill, Inc. (NYSE: JILL) climbed 26.45 percent to close at $7.84 after the company posted upbeat quarterly earnings.
    Curis, Inc. (NASDAQ: CRIS) shares climbed 21.93 percent to close at $2.78 in reaction to an encouraging FDA update. The biotechnology company that focuses on therapies for the treatment of cancer said the FDA granted a Fast Track designation for fimepinostat (CUDC-907) in patients with relapsed or refractory.
    Boxlight Corporation (NASDAQ: BOXL) gained 21.23 percent to close at $7.48.
    Kirkland's, Inc. (NASDAQ: KIRK) rose 16.21 percent to close at $12.83 after reporting upbeat Q1 results.
    The Brink's Company (NYSE: BCO) jumped 16.2 percent to close at $79.25 as the company announced plans to acquire Dunbar Armored for $520 million in cash.
    Applied Optoelectronics, Inc. (NASDAQ: AAOI) rose 15.14 percent to c
  • [By Shane Hupp]

    Stifel Nicolaus started coverage on shares of LivaNova (NASDAQ:LIVN) in a research report released on Friday morning, Marketbeat Ratings reports. The brokerage issued a buy rating and a $115.00 target price on the stock.

  • [By Lisa Levin] Gainers
    Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) jumped 124.8 percent to $243.725 in reaction to an encouraging Phase 2 clinical trial update. The clinical-stage biopharmaceutical company said its liver-directed, thyroid hormone receptor called MGL-3196 showed a statistical significance in the primary endpoint of lowering liver fat at 12 weeks and also 36 weeks.
    Viking Therapeutics, Inc. (NASDAQ: VKTX) gained 63.4 percent to $8.12 after falling 4.42 percent on Wednesday.
    Takung Art Co., Ltd. (NYSE: TKAT) rose 43.3 percent to $2.9094
    vTv Therapeutics Inc. (NASDAQ: VTVT) shares climbed 29.7 percent to $2.16 after the company reported a licensing deal with Newsoara Biopharma to rights for vTv's PDE4 Inhibitor in China and other Pacific Rim territories.
    Akers Biosciences, Inc. (NASDAQ: AKER) gained 26.2 percent to $0.4109. The developer of rapid health information technologies said Wednesday afternoon it was granted a 180-day extension from the Nasdaq Stock Market to meet the requirement of a minimum $1.00 per share closing bid price for 10 straight days.
    Genprex, Inc. (NASDAQ: GNPX) rose 22.2 percent to $11.6254. Genprex reported engagement of WIRB-Copernicus Group to provide clinical trial services to support Oncoprex clinical trial program.
    J.Jill, Inc. (NYSE: JILL) gained 21 percent to $7.506 after the company posted upbeat quarterly earnings.
    Urban One, Inc. (NASDAQ: UONE) gained 19.7 percent to $3.95 after rising 78.38 percent on Wednesday.
    TapImmune, Inc. (NASDAQ: TPIV) shares gained 18.5 percent to $6.03 after climbing 24.15 percent on Wednesday.
    Kirkland's, Inc. (NASDAQ: KIRK) rose 17.3 percent to $12.95 after reporting upbeat Q1 results.
    CymaBay Therapeutics, Inc. (NASDAQ: CBAY) shares gained 15.1 percent to $13.210.
    The Brink's Company (NYSE: BCO) climbed 14.2 percent to $77.875 as the company announced plans to acquire Dunbar Armored for $520 million in cash.
    Keysight Technologies, Inc. (NYSE: KEY

Leave a Reply

Your email address will not be published. Required fields are marked *